EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Interplay Between Sex and Cytosine‐Adenine‐Guanine‐Age Product Score in Huntington's Disease: Clinical and Neuroimaging Perspectives

Jingwen Yao iD, Grayson Feng, Guowen Shao, Zexi Wang, Adys Mendizabal iD, Donatello Telesca, Kaiying Fang, Lola Ibragimova, Juwairia Shoaib, Melanie A Morrison, Janine M Lupo

Movement Disorders · 2025

DOI: 10.1002/mds.70064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Jingwen Yao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Huntington Disease, Sex Characteristics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a cytosine‐adenine‐guanine (CAG) repeat expansion in the huntingtin gene. The disease exhibits sex‐related differences in symptomatology and disease progression, but the effect on brain structural biomarkers and the interaction between sex and CAG‐age product score (CAPS), a widely used index combining the effect of CAG expansion and age, remains underexplored.

Objective

The aim of this study was to investigate the interplay between sex and CAPS on clinical measures and neuroimaging biomarkers in HD.

Methods

We retrospectively analyzed data from Enroll‐HD, TRACK‐HD/ON, PREDICT‐HD, and IMAGE‐HD studies, including a combined dataset of 19,738 participants with CAG ≥ 40. Linear mixed models were employed to evaluate the influence of sex and the sex‐CAPS interaction on clinical evaluations, including Unified HD Rating Scale (UHDRS) UHDRS and Problem Behaviors Assessment, and neuroimaging biomarkers (striatal volumes and cortical thickness), while controlling for covariates.

Results

Female participants exhibited less pronounced striatal atrophy and cortical thinning with increasing CAPS (caudate: = −3.449/−2.931, P = 0.05; putamen: = −4.770/−3.902, P < 0.01). Regarding clinical measures, females experience greater motor decline with increasing CAPS (total motor score: = 3.008/3.230, P < 0.0001), greater cognitive decline (symbol digit modalities test: = −34.52/−38.57, P < 0.0001), and greater functional decline (total functional capacity: = −6.413/−6.783, p < 0.05; Independence Scale: = −32.26/−34.85, P < 0.001).

Conclusions

The sex‐CAPS interaction significantly impacts both clinical and neuroimaging biomarkers of HD, underscoring the importance of incorporating sex‐specific considerations into the clinical staging and management of HD. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseSex CharacteristicsHumansMaleFemaleMiddle AgedAdultRetrospective StudiesTrinucleotide Repeat ExpansionNeuroimagingAgedHuntingtin ProteinMagnetic Resonance ImagingSex Factors

Stichwörter der Autor:innen

Huntington's diseaseneuroimagingsex difference

Substanzen

Huntingtin Protein

Autor:innen und Institutionen

  • Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, Los Angeles, California, USA.
  • Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Department of Biostatistics, University of California, Los Angeles, Los Angeles, California, USA.
  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA.
  • UCSF/UC Berkeley Graduate Program in Bioengineering, University of California, San Francisco, San Francisco, California, USA.

ORCID-Profile: Jingwen Yao, Adys Mendizabal

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Yao, J., Feng, G., Shao, G., Wang, Z., Mendizabal, A., Telesca, D., Fang, K., Ibragimova, L., Shoaib, J., Morrison, M. A., & Lupo, J. M. (2025). Interplay Between Sex and Cytosine‐Adenine‐Guanine‐Age Product Score in Huntington's Disease: Clinical and Neuroimaging Perspectives. Movement Disorders. https://doi.org/10.1002/mds.70064

Vancouver

Yao J, Feng G, Shao G, Wang Z, Mendizabal A, Telesca D, et al. Interplay Between Sex and Cytosine‐Adenine‐Guanine‐Age Product Score in Huntington's Disease: Clinical and Neuroimaging Perspectives. Movement Disorders. 2025. doi:10.1002/mds.70064

BibTeX
@article{Yao2025,
  author = {Yao, Jingwen and Feng, Grayson and Shao, Guowen and Wang, Zexi and Mendizabal, Adys and Telesca, Donatello and Fang, Kaiying and Ibragimova, Lola and Shoaib, Juwairia and Morrison, Melanie A and Lupo, Janine M},
  title = {Interplay Between Sex and Cytosine‐Adenine‐Guanine‐Age Product Score in Huntington's Disease: Clinical and Neuroimaging Perspectives},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.70064}
}
Kostenlos starten →